Edition:
United States

Clearside Biomedical Inc (CLSD.OQ)

CLSD.OQ on NASDAQ Stock Exchange Global Market

5.48USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$5.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
78,495
52-wk High
$15.27
52-wk Low
$5.26

Chart for

About

Clearside Biomedical, Inc. is a clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye. The Company's product candidates focus on diseases affecting the retina, which is the tissue that lines the inside of the eye and is primarily responsible for vision, and the choroid,... (more)

Overall

Beta: --
Market Cap(Mil.): $185.74
Shares Outstanding(Mil.): 32.02
Dividend: --
Yield (%): --

Financials

  CLSD.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -2.64 -- --
ROI: -104.28 1.96 12.83
ROE: -119.24 1.12 14.95

BRIEF-Clearside Biomedical Q1 Loss Per Share $0.62

* CLEARSIDE BIOMEDICAL ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 09 2018

Competitors

Earnings vs. Estimates